Budzinski questions TrumpRx savings, highlights PBM reforms and IRA drug negotiations
Axios Live interviewed Rep. Nikki Budzinski (D-IL) on GLP-1 affordability, compounding pharmacies, and broader drug cost issues. Segments covered the Inflation Reduction Act's Medicare negotiations, skepticism of TrumpRx, PBM reform via the Pharmacists Fight Back Act, price transparency, telehealth flexibilities, preventive care, and biomanufacturing investments including a $51M grant.
Source: Axios Live